tainted heparin Tagged Articles

Daschle likely to inherit agency rife with issues

Posted: December 8, 2008 Pharmaceutical

President-elect Barack Obama has made no formal announcement as yet, but it appears likely that Sen. Tom Daschle will be appointed Obama’s choice for Health and Human Services secretary, according to The Federal Times. If so, Dashle will inherit a

Generics may be bio-equivalent of brands, but are they as safe?

Posted: December 5, 2008 Pharmaceutical

Clinical tests conducted by the Journal of the American Medical Association comparing brand and generic cardiovascular drugs show that generic drugs are bio-equivalent to the drugs they are patterned after. And, the FDA adds, generics are far less expensive than

Baxter International spent thousands on lobbying efforts

Posted: November 27, 2008 Pharmaceutical

Drug maker Baxter International Inc., shelled out more than $720,000 in the third quarter of the year lobbying on health care issues including government reimbursement for kidney dialysis treatment and increased funding for kidney disease education, according to Forbes/Associated Press.

Lawmaker questions FDA investigation of heparin scandal

Posted: November 21, 2008 Pharmaceutical

A Washington lawmaker is raising concerns about the FDA’s handling of the tainted heparin scandal earlier this year, claiming that the agency misrepresented deaths tied to the product and didn’t thoroughly investigate the situation, according to CNN Money.

FDA will not name Chinese plants that supplied tainted heparin

Posted: October 27, 2008 Pharmaceutical

The U.S. Food and Drug Administration (FDA) is at odds with congressional investigators over an investigation into the federal agency’s inspection of foreign drug manufacturing facilities.

Despite recall, Baxter International enjoys third-quarter gains

Posted: October 21, 2008 Pharmaceutical

Despite heparin-recall woes earlier in the year, Pharmaceutical drug giant Baxter International announced that it had a 19 percent increase in third-quarter profits, according to a Baxter International press release.

FDA to set up offices worldwide

Posted: October 17, 2008 Pharmaceutical

The U.S. Food and Drug Administration (FDA) will place more than 60 food and drug regulators worldwide over the next year to provide guidance on U.S. quality standards, according to the Associated Press. This will replace the agency’s current practice

FDA makes blunder during hiring of PR firm to improve image

Posted: October 2, 2008 Pharmaceutical

Every company can use a good spin doctor from time to time, and it looks like the Food and Drug Administration (FDA) is no exception. Last month I told you that California Rep. Harry Waxman, who serves as head of

synthetic heparin in development

Posted: August 18, 2008 Pharmaceutical

Robert Linhardt, a scientist at Troy, New York-based Rensselaer Polytechnic Institute, is leading a team of researchers who have developed a fully synthetic version of the blood thinner heparin. While the group has only produced a few milligrams of the